Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor I and glycogen synthase kinase-3β inhibitors

Endocrinology

Volumn 146, Issue 7, 2005, Pages 3141-3149

  Fang, Cheng Hui ^a   Li, Bing Guo ^a   James, J Howard ^a,b   King, Jy Kung ^a,b   Evenson, Amy R ^c   Warden, Glenn D ^a,b   Hasselgren, Per Olof ^c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCINEURIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPROTEIN; LITHIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN; PROTEIN KINASE B; RAPAMYCIN; SOMATOMEDIN C; THIADIAZOLE DERIVATIVE; THIADIAZOLIDINONE 8; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; WORTMANNIN; 4 BENZYL 2 METHYL 1,2,4 THIADIAZOLIDINE 3,5 DIONE; 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE; AKT1 PROTEIN, RAT; DNA BINDING PROTEIN; ENZYME INHIBITOR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MUSCLE PROTEIN; NERVE PROTEIN; ONCOPROTEIN; PEPTIDE HYDROLASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BURN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; EXTENSOR DIGITORUM LONGUS MUSCLE; ISOLATED ORGAN; MALE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; HINDLIMB; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TOE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BURNS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; FORKHEAD TRANSCRIPTION FACTORS; GLYCOGEN SYNTHASE KINASE 3; HINDLIMB; INSULIN-LIKE GROWTH FACTOR I; LITHIUM CHLORIDE; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; THIADIAZOLES; TOES;

EID: 22144453941     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0869     Document Type: Article

References (46)

1. Clark AS, Kelly RA, Mitch WE 1984 Systemic response to thermal injury in rats. Accelerated protein degradation and altered glucose utilization in muscle. J Clin Invest 74:888-897
2. Downey RS, Monafo WW, Karl IE, Matthews DE, Bier DM 1986 Protein dynamics in skeletal muscle after trauma: local and systemic effects. Surgery 99:265-274
3. Fang CH, Tiao G, James H, Ogle C, Fischer JE, Hasselgren PO 1995 Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Coll Surg 180:161-170
4. Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, Ferrando AA, Wolfe RR, Herndon DN 2000 Persistence of muscle catabolism after severe burn. Surgery 128:312-319
5. Debroy MA, Wolf SE, Zhang XJ, Chinkes DL, Ferrando AA, Wolfe RR, Herndon DN 1999 Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma 47:904-911
6. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR 2001 Reversal of catabolism by β-blockade after severe burns. N Engl J Med 345:1223-1229
7. Fang CH, Li BG, Wang JJ, Fischer JE, Hasselgren PO 1997 Insulin-like growth factor 1 stimulates protein synthesis and inhibits protein breakdown in muscle from burned rats. J Parenter Enteral Nutr 21:245-251
8. Fang CH, Li BG, Wray CJ, Hasselgren PO 2002 Insulin-like growth factor-I inhibits lysosomal and proteasome-dependent proteolysis in skeletal muscle after burn injury. J Burn Care Rehabil 23:318-325
9. Fang CH, Li BG, Wang JJ, Fischer JE, Hasselgren PO 1998 Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle. Am J Physiol 275:R1091-R1098
10. Cioffi WG, Gore DC, Rue III LW, Carrougher G, Guler HP, McManus WF, Pruitt Jr BA 1994 Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 220:310-319
11. Wolf SE, Barrow RE, Herndon DN 1996 Growth hormone and IGF-I therapy in the hypercatabolic patient. Baillieres Clin Endocrinol Metab 10:447-463
12. 3K/Akt/GSK3 pathways. Nat Cell Biol 3:1009-1013
13. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412
14. Stitt TN, Drijan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ 2004 The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403
15. Tsakiridis T, Tsiani E, Lekas P, Bergman A, Cherepanov V, Whiteside C, Downey GP 2001 Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells. Biochem Biophys Res Commun 288:205-211
16. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P 1994 The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303:21-26
17. + transport in rat soleus muscle. Am J Physiol 268:E849-E857
18. Secrist JA, Barrio JR, Leonard NJ, Weber G 1972 Fluorescent modification of adenosine-containing coenzymes. Biochemistry 11:3499-3506
19. Kawamoto Y, Shinozuka K, Kunitomo M, Haginaka J 1998 Determination of ATP and its metabolites released from rats caudal artery by isocratic ion-pair reversed-phase high-performance liquid chromatography. Anal Biochem 262:33-38
20. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
21. Wei W, Fareed MU, Evenson A, Menconi MJ, Yang H, Petkova V, Hasselgren PO 2005 Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3. Am J Physiol 288:R580-R590
22. Dardevet D, Sornet C, Vary T, Grizard J 1996 Phosphatidylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 137:4087-4094
23. Angeras U, Hall-Angeras M, Wagner KR, James H, Hasselgren PO, Fischer JE 1991 Tissue metabolite levels in different types of skeletal muscle during sepsis. Metabolism 40:1147-1151
24. Ryves WJ, Harwood AJ 2001 Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720-725
25. Martinez A, Alonso M, Castro A, Perez C, Moreno FJ 2002 First non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J Med Chem 45:1292-1299
26. Chalecka-Franaszek E, Chuang DM 1999 Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 in neurons. Proc Natl Acad Sci USA 96:8745-8750
27. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL 2004 Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18:39-51
28. Wray CJ, Mammen JMV, Hershko D, Hasselgren PO 2003 Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35:698-705
29. s6k. Crit Rev Biochem Mol Biol 29:385-413
30. s6k. FEBS Lett 410:78-82
31. Li Z, Jiang Y, Ulevitch RJ, Han J 1996 The primary structure of p38γ: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228:334-340
32. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N 1999 IGF-I induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400:581-585
33. Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Allen DG, Harvey RP, Graham RM 1999 Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 400:576-581
34. Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW 2002 GSK-3β negatively regulates skeletal myotube hypertrophy. Am J Physiol 283:C545-C551
35. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL 2004 IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol 287:E591-E601
36. Blommaart EF, Krause U, Schellens JP, Sindelarova HV, Meijer AJ 1997 The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated hepatocytes. Eur J Biochem 243:240-246
37. Wurmser AE, Emr SD 2002 Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy. J Cell Biol 158:761-772
38. Mousavi SA, Brech A, Berg T, Kjeken R 2003 Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes. Biochem J 372:861-869
39. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD 2001 Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019
40. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272:6653-6662
41. Han J, Lee JD, Bibbs L, Ulevitch RJ 1994 A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811
42. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNutty D, Blumenthal MJ, Heys JR, Landvatter SW 1994 A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746
43. Fang CH, Li BG, James JH, Fischer JE, Hasselgren PO 1998 The anabolic effects of IGF-I in skeletal muscle after burn injury are not caused by increased cell volume. J Parenter Enteral Nutr 22:115-119
44. Ikezu T, Okamoto T, Yonezawa K, Tompkins RG, Martyn JA 1997 Analysis of thermal injury-induced insulin resistance in rodents. Implication of post-receptor mechanisms. J Biol Chem 272:25289-25295
45. Sugita H, Kaneki M, Sugita M, Yasukawa T, Yasuhara S, Martyn JA 2005 Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol 288:E585-E591
46. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34